FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

32898611000001109: Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 20-Jul 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
100261701000001119 Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
100261801000001111 Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has dispensed dose form Nebuliser liquid false Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has dispensed dose form Nebuliser liquid true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Is a Salbutamol 1mg/ml / Ipratropium bromide 200micrograms/ml nebuliser liquid 2.5ml ampoules true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has active ingredient Ipratropium true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has active ingredient Salbutamol true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has manufactured dose form Inhalation dosage form false Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has specific active ingredient Salbutamol sulfate true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has specific active ingredient Ipratropium bromide true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has dispensed dose form Nebulizer liquid false Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Is a Salipraneb true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) VMP non-availability indicator Re-introduced false Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Has basis of strength substance Salbutamol true Inferred relationship Existential restriction modifier
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) 60 ampoule 6 x 10 ampoules Has AMP True Salipraneb 0.5mg/2.5mg nebuliser solution 2.5ml ampoules (Actavis UK Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start